Nalaganje...
Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer
Hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-positive (HR+/HER2+) advanced breast cancer is a special subtype of cancer with unique features. Major guidelines recommend that combination therapy containing anti-HER2 therapy (e.g., trastuzumab and pertuzumab) should b...
Shranjeno v:
| izdano v: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8111512/ https://ncbi.nlm.nih.gov/pubmed/33995599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211013326 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|